PECOMA OF THE TALUS, A RARE CASE AND THE LITERATURE REVIEW

Öz

Perivascular epithelioid cell neoplasms (PEComas) are mesenchymal tumors which evolve out of the perivascular epithelioid cells (PECs).Soft tissue, visceral organs, and skin are the most encountered body regions. Primary bone PEComas,especially PEComas of talus, are remarkably rare; best of our knowledge, only sixteen primary bone PEComa cases have reported since defined in 2002. We report a 51-year-old male presented with PEComa of the talus and review the literature.

Anahtar Kelimeler

• PEComa
• PEComa of bone
• PEComa of talus
• foot tumor
• soft tissue tumor

Proje Numarası

.

TALUSTA PECOMA, NADİR BİR OLGU VE LİTERATÜR DERLEMESİ

Öz

Perivasküler epiteloid hücreli neoplazmlar (PEComalar), perivasküler epiteloid hücrelerden (PEC’ler) gelişen mezenkimal tümörlerdir. Yumuşak doku, iç organlar ve deri en çok karşılaşılan vücut bölgeleridir. Primer kemik PEComaları, özellikle talusun PEComaları oldukça nadirdir; Bilgimize göre 2002’den bu yana yalnızca 16 primer kemik PEComa vakası rapor edilmiştir. Biz de, talusta PEComa ile başvuran 51 yaşında bir erkek hasta ve literatür derlemesini rapor ediyoruz.,

Anahtar Kelimeler

• PEComa
• kemik PEComası
• talus PEComası
• ayak tümörü
• yumuşak doku tümörü

Destekleyen Kurum

yok

Proje Numarası

.

Etik Beyan

Olgu sunumu olduğu için etik kurul onayı alınmamıştır

Teşekkür

.

Kaynakça

1. Yamashita K, Fletcher CD. PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review. The American journal of surgical pathology. 2010;34(11):1622-9. Epub 2010/10/27.
2. Masson P. Origin of fibromyolipomas. Human tumors Histology, Diagnosis and Technique: Wayne State University Press Detroit; 1970. p. 735-6.
3. Bonetti F, Pea M, Martignoni G, et al. The American journal of surgical pathology. 1992;16(3):307.
4. Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Archiv. 2008;452(2):119-32.
5. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Human pathology. 2010;41(1):1-15.
6. Bleeker JS, Quevedo JF, Folpe AL. “Malignant” perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma. 2012;2012.
7. Gebhart M, Coltofeanu A. PEComa of the talus: a unique case of a soft tissue tumor within bone. Acta Chirurgica Belgica. 2019;119(2):118-22.
8. Insabato L, De Rosa G, Terracciano L, et al. Primary monotypic epithelioid angiomyolipoma of bone. Histopathology. 2002;40(3):286-90.

9. Técualt-Gómez R, Atencio-Chan A, Amaya-Zepeda R, et al. Neoplasia de células epiteloides perivasculares (PEComa) tibial. Reporte de un caso y revisión de la literatura. Revista Española de Cirugía Ortopédica y Traumatología. 2019;63(3):239-45.
10. Karpathiou G, Barral FG, Habougit C, et al. The eight year evolution of an osseous PEComa. Pathology international. 2017;67(3):181.
11. Lian D, Chuah K, Cheng M, Yap W. Malignant perivascular epithelioid cell tumour of the fibula: a report and a short review of bone perivascular epithelioid cell tumour. Journal of clinical pathology. 2008;61(10):1127-9.
12. Righi A, Dimosthenous K, Rosai J. PEComa: another member of the MiT tumor family? International Journal of Surgical Pathology. 2008;16(1):16-20.
13. Torii I, Kondo N, Takuwa T, et al. Perivascular epithelioid cell tumor of the rib. Virchows Archiv. 2008;452(6):697-702.
14. Desy NM, Bernstein M, Nahal A, et al. Primary perivascular epithelioid cell neoplasm (PEComa) of bone: report of two cases and review of the literature. Skeletal radiology. 2012;41(11):1469-74.
15. Untrauer JB, Giannini PJ, Talmon GA, et al. Malignant PEComa involving the mandible: report of a unique case. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2014;117(1):e3-e8.
16. Kazzaz D, Khalifa M, Alorjan M, et al. Malignant PEComa of the lumbar vertebra: a rare bone tumour. Skeletal radiology. 2012;41(11):1465-8.
17. Lao IW, Yu L, Wang J. Malignant perivascular epithelioid cell tumor (PEComa) of the femur: A case report and literature review. Diagnostic Pathology. 2015;10(1):54.
18. Sun L, Sun X, Li Y, Xing L. The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor. OncoTargets and therapy. 2015;8:1967.